Is Medtronic Stock a Buy at 14x Forward Earnings?

10:21am, Wednesday, 10'th Jun 2026
MDT trades at about 14x forward earnings with a 3.5% yield as fiscal 2027 guidance points to steady growth, but margins face tariffs and mix pressure.
Even the hottest AI stocks won't win forever. Diversification is the key to long-term wealth.
Tech stocks are pulling back, and healthcare is surging.
Medtronic plc is a sleepy Dividend Aristocrat with the potential for dividend growth to reaccelerate in the next 12 to 24 months. MDT beat the analyst consensus for revenue and non-GAAP EPS in Q4 2026
Medtronic recently reported strong results, highlighting impressive growth.
Medtronic's Hugo robotic-assisted surgery platform is approved in the U.S. for urologic procedures, and has more applications pending. Intuitive Surgical's da Vinci is the market's flagship platform,
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Lowe's, Medtronic, and UnitedHealth Group have been solid dividend growth stocks over the years. They offer above-average payouts and their valuations are also attractive.
On Wednesday, Medtronic plc (NYSE:MDT) reported fourth-quarter revenue that exceeded Wall Street expectations, supported by strong growth in its Cardiovascular and Diabetes businesses.

Medtronic Bottoms, Healthy Rebound Ahead

01:10pm, Thursday, 04'th Jun 2026
Medtronic's NYSE: MDT primary catalyst as mid-year approaches is that headwinds are not impairing results as much as feared. Rising costs, margin compression, and general uncertainty linked to macroec
MDT touts FY26 as a turning point, keeps FY27 growth targets high, and spotlights CAS and new platforms as investors press on tariffs and TAVR.
Medtronic plc (MDT) Q4 2026 Earnings Call Transcript
Revenue: $9.8 billion in Q4, up 9.9% reported and 6.6% organically; $36.4 billion for FY26, up 8.4% reported and 5.8% organically.Adjusted EPS: $1.55 for Q4 an

Why Medtronic Stock Popped Today

01:57pm, Wednesday, 03'rd Jun 2026
Medtronic just wrapped up its best year in a decade.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE